204
Views
49
CrossRef citations to date
0
Altmetric
Review

Danish Gynecological Cancer Database

, , , , , , & show all
Pages 485-490 | Published online: 25 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rikke Langballe, Mef Christina Nilbert, Jane Christensen, Anne Julie Tybjerg & Pernille Envold Bidstrup. (2022) Understanding quality data correctly: a randomized comparison of presentation formats among cancer patients and relatives. Acta Oncologica 61:12, pages 1454-1462.
Read now
Linda A. Rasmussen, Henry Jensen, Line F. Virgilsen, Mette M. Jeppesen, Jan Blaakaer, Dorte G. Hansen, Pernille T. Jensen, Ole Mogensen & Peter Vedsted. (2021) Identification of endometrial cancer recurrence – a validated algorithm based on nationwide Danish registries. Acta Oncologica 60:4, pages 452-458.
Read now
Morten Schmidt, Sigrun Alba Johannesdottir Schmidt, Kasper Adelborg, Jens Sundbøll, Kristina Laugesen, Vera Ehrenstein & Henrik Toft Sørensen. (2019) The Danish health care system and epidemiological research: from health care contacts to database records. Clinical Epidemiology 11, pages 563-591.
Read now
Mette Calundann Noer, Pia Leandersson, Torbjørn Paulsen, Susanne Rosthøj, Sofie Leisby Antonsen, Christer Borgfeldt & Claus Høgdall. (2018) Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients – a comparative cohort study. Acta Oncologica 57:8, pages 1100-1108.
Read now

Articles from other publishers (45)

Hans H.B. Wenzel, Anna N. Hardie, Arturo Moncada-Torres, Claus K. Høgdall, Ruud L.M. Bekkers, Henrik Falconer, Pernille T. Jensen, Hans W. Nijman, Maaike A. van der Aa, Frank Martin, Anna J. van Gestel, Valery E.P.P. Lemmens, Pernilla Dahm-Kähler, Emilia Alfonzo, Jan Persson, Linnea Ekdahl, Sahar Salehi, Ligita P. Frøding, Algirdas Markauskas, Katrine Fuglsang & Tine H. Schnack. (2023) A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases. European Journal of Cancer 185, pages 61-68.
Crossref
Stinne Holm Bergholdt, Dorte Gilsaa Hansen, Anna Thit Johnsen, Bo Snedker Boman & Pernille Tine Jensen. (2023) A NEw MOdel of individualized and patient-centered follow-up for women with gynecological cancer (the NEMO study)—protocol and rationale of a randomized clinical trial. Trials 24:1.
Crossref
Sudha Sundar, Andy Nordin, Jo Morrison, Nick Wood, Sadaf Ghaem-Maghami, Jo Nieto, Andrew Phillips, John Butler, Kevin Burton, Rob Gornall, Stephen Dobbs, Rosalind Glasspool, Richard Peevor, Jonathan Ledermann, Iain McNeish, Nithya Ratnavelu, Tim Duncan, Jonathan Frost, Kenneth Lim, Agnieszka Michael, Elly Brockbank, Ketankumar Gajjar, Alexandra Taylor, Rebecca Bowen, Adrian Andreou, Raji Ganesan, Shibani Nicum, Richard Edmondson, Richard Clayton, Janos Balega, Phil Rolland, Hilary Maxwell & Christina Fotopoulou. (2023) British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer. Cancers 15:2, pages 337.
Crossref
Anne Weng Ekmann-Gade, Tine Henrichsen Schnack, Lene Seibæk, Mette Calundann Noer & Claus Høgdall. (2023) Impact of surgery and chemotherapy timing on outcomes in older versus younger epithelial ovarian cancer patients: A nationwide Danish cohort study. Journal of Geriatric Oncology 14:1, pages 101359.
Crossref
Nishita M S Baldewpersad Tewarie, Maaike van Ham, Michel Wouters, Roy Kruitwagen & Willemien van Driel. (2022) Guideline adherence in ovarian cancer for surgical staging in the Netherlands. International Journal of Gynecologic Cancer 32:12, pages 1592-1598.
Crossref
Yagmur Sisman, Lau Kræsing Vestergaard, Douglas Nogueira Perez de Oliveira, Tim Svenstrup Poulsen, Tine Henrichsen Schnack, Claus Høgdall & Estrid Høgdall. (2022) Potential Targeted Therapies in Ovarian Cancer. Pharmaceuticals 15:11, pages 1324.
Crossref
Tine Henrichsen Schnack, Ligita Paskeviciute Froeding, Elisabeth Kristensen, Isa Niemann, Gitte Ørtoft, Estrid Høgdall & Claus Høgdall. (2022) Preoperative predictors of inguinal lymph node metastases in vulvar cancer – A nationwide study. Gynecologic Oncology 165:3, pages 420-427.
Crossref
Alicia Leon-Castillo, Nanda Horeweg, Elke E.M. Peters, Tessa Rutten, Natalja ter Haar, Vincent T.H.B.M. Smit, Cor D. Kroon, Marie Boennelycke, Estrid Hogdall, Claus Hogdall, Remi R.A. Nout, Carien L. Creutzberg, Gitte Ortoft & Tjalling Bosse. (2022) Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment. Gynecologic Oncology 164:3, pages 577-586.
Crossref
Julie L. Schleiss-Andreassen, Elisabeth Kristensen, Ligita Paskeviciute Frøding, Estrid Stæhr, Claus Høgdall, Anne Pernille Christiansen, Estrid Høgdall & Tine Henrichsen Schnack. (2022) Assessment of recurrence rate and risk factors of relapse in stage in IA vulvar carcinoma. Gynecologic Oncology 164:3, pages 543-549.
Crossref
M.T. Faber, T.A. Horsbøl, L. Baandrup, S.O. Dalton & S.K. Kjaer. (2022) Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996–2017. Gynecologic Oncology 164:1, pages 98-104.
Crossref
Anne Weng Ekmann-Gade, Claus Kim Høgdall, Lene Seibæk, Mette Calundann Noer, Carsten Lindberg Fagö-Olsen & Tine Henrichsen Schnack. (2022) Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study. Gynecologic Oncology 164:1, pages 120-128.
Crossref
Douglas V.N.P. Oliveira, Julie Hentze, Colm J. O’Rourke, Jesper B. Andersen, Claus Høgdall & Estrid V. Høgdall. (2021) DNA Methylation in Ovarian Tumors—a Comparison Between Fresh Tissue and FFPE Samples. Reproductive Sciences 28:11, pages 3212-3218.
Crossref
Douglas V. N. P. Oliveira, Tine H. Schnack, Tim S. Poulsen, Anne P. Christiansen, Claus K. Høgdall & Estrid V. Høgdall. (2021) Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures. Cancers 13:20, pages 5242.
Crossref
Lau K. Vestergaard, Douglas N. P. Oliveira, Tim S. Poulsen, Claus K. Høgdall & Estrid V. Høgdall. (2021) Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus. Cancers 13:20, pages 5230.
Crossref
Malene Korsholm, Dorte Gyrd‐Hansen, Ole Mogensen, Sören Möller, Siv L. Joergensen & Pernille T. Jensen. (2021) Post robotic investment: Cost consequences and impact on length of stay for obese women with endometrial cancer. Acta Obstetricia et Gynecologica Scandinavica 100:10, pages 1830-1839.
Crossref
Koray ASLAN, Zeliha FIRAT CÜYLAN, Şükran KOZALI & Murat ÖZ. (2021) EPİTELİYAL OVER KANSERİNDE UZUN DÖNEM SAĞ KALIMLA İLİŞKİLİ KLİNİK VE EPIDEMİYOLOJİK ÖZELLİKLERCLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS ASSOCIATED WITH LONG-TERM SURVIVAL IN EPITHELIAL OVARİAN CANCER. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 18:3, pages 901-906.
Crossref
Marie Boennelycke, Elke E. M. Peters, Alicia Léon-Castillo, Vincent T. H. B. M. Smit, Tjalling Bosse, Ib Jarle Christensen, Gitte Ørtoft, Claus Høgdall & Estrid Høgdall. (2021) Prognostic impact of histological review of high-grade endometrial carcinomas in a large Danish cohort. Virchows Archiv 479:3, pages 507-514.
Crossref
Gitte Ortoft, Claus Høgdall, Estrid Stæhr Hansen & Margit Dueholm. (2021) Predictive value of the new ESGO-ESTRO-ESP endometrial cancer risk classification on survival and recurrence in the Danish population. International Journal of Gynecologic Cancer 31:8, pages 1116-1124.
Crossref
Joanna Lopacinska-Jørgensen, Douglas V. N. P. Oliveira, Guy Wayne Novotny, Claus K. Høgdall & Estrid V. Høgdall. (2021) Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer. PLOS ONE 16:7, pages e0255142.
Crossref
Kira Philipsen Prahm, Claus Kim Høgdall, Mona Aarenstrup Karlsen, Ib Jarle Christensen, Guy Wayne Novotny & Estrid Høgdall. (2021) MicroRNA characteristics in epithelial ovarian cancer. PLOS ONE 16:6, pages e0252401.
Crossref
M.T. Faber, C.D. Sperling, A.K.K. Bennetsen, G.L. Aalborg & S.K. Kjaer. (2021) A Danish nationwide study of risk factors associated with Type I and Type II endometrial cancer. Gynecologic Oncology 161:2, pages 553-558.
Crossref
Cecilie Dyg Sperling, Freija Verdoodt, Gitte Lerche Aalborg, Christian Dehlendorff, Søren Friis & Susanne K. Kjaer. (2021) Non-aspirin NSAID use and mortality of endometrial cancer. A nationwide cohort study. Cancer Causes & Control 32:5, pages 515-523.
Crossref
Douglas V. N. P. Oliveira, Kira P. Prahm, Ib J. Christensen, Anker Hansen, Claus K. Høgdall & Estrid V. Høgdall. (2020) Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases. Reproductive Sciences 28:3, pages 757-765.
Crossref
Dorthe Hjort Jakobsen, Claus Høgdall & Lene Seibæk. (2021) Postoperative mobilisation as an indicator for the quality of surgical nursing care. British Journal of Nursing 30:4, pages S4-S15.
Crossref
Charles H Norell, John Butler, Rhonda Farrell, Alon Altman, James Bentley, Citadel J Cabasag, Paul A Cohen, Scott Fegan, Michael Fung-Kee-Fung, Charlie Gourley, Neville F Hacker, Louise Hanna, Claus Kim Høgdall, Gunnar Kristensen, Janice Kwon, Orla McNally, Gregg Nelson, Andy Nordin, Dearbhaile O'Donnell, Tine Schnack, Peter H Sykes, Ewa Zotow & Samantha Harrison. (2020) Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care. International Journal of Gynecologic Cancer 30:11, pages 1748-1756.
Crossref
Pernille T. Jensen, Tine H. Schnack, Ligita P. Frøding, Signe F. Bjørn, Henrik Lajer, Algirdas Markauskas, Kirsten M. Jochumsen, Katrine Fuglsang, Jacob Dinesen, Charlotte H. Søgaard, Erik Søgaard-Andersen, Marianne M. Jensen, Aage Knudsen, Laura H. Øster & Claus Høgdall. (2020) Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer – A population-based study. European Journal of Cancer 128, pages 47-56.
Crossref
Cecilie D Sperling, Freija Verdoodt, Gitte L Aalborg, Christian Dehlendorff, Søren Friis & Susanne K Kjaer. (2020) Low-dose aspirin use and endometrial cancer mortality—a Danish nationwide cohort study. International Journal of Epidemiology 49:1, pages 330-337.
Crossref
Berit Jul Mosgaard, Amani Meaidi, Claus Høgdall & Mette Calundann Noer. (2020) Risk factors for early death among ovarian cancer patients: a nationwide cohort study. Journal of Gynecologic Oncology 31:3.
Crossref
Gitte Ørtoft, Claus Høgdall, Estrid S. Hansen & Margit Dueholm. (2020) Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study. Journal of Gynecologic Oncology 31:2.
Crossref
Ligita Paskeviciute Froeding, Claus Høgdall, Elisabeth Kristensen, Vibeke Zobbe, Isa Niemann, Gitte Ørtoft, Ingrid Thranov, Ole Mathiesen, Jann Mortensen & Tine Henrichsen Schnack. (2020) Recurrence and survival rates in node negative patients after sentinel node biopsy for early-stage vulva cancer – A nationwide study. Gynecologic Oncology 156:1, pages 124-130.
Crossref
Marie‐Louise Ladegaard Baun, Alina Z. Falborg, Peter Hjertholm, Lone K. Petersen & Peter Vedsted. (2019) Ovarian cancer stage, variation in transvaginal ultrasound examination rates and the impact of an urgent referral pathway: A national ecological cohort study. Acta Obstetricia et Gynecologica Scandinavica 98:12, pages 1540-1548.
Crossref
Douglas Nogueira Perez Oliveira, Anting Liu Carlsen, Niels H. H. Heegaard, Kira Philipsen Prahm, Ib Jarle Christensen, Claus K. Høgdall & Estrid V. Høgdall. (2019) Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass. PLOS ONE 14:11, pages e0225249.
Crossref
Marie-Louise L Baun, Henry Jensen, Alina Z Falborg, Hanne N Heje, Lone K Petersen & Peter Vedsted. (2019) Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study. Family Practice 36:6, pages 751-757.
Crossref
E.M. Hengeveld, P.L.M. Zusterzeel, H. Lajer, C.K. Høgdall & M. Rosendahl. (2019) The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma. Gynecologic Oncology 154:2, pages 308-313.
Crossref
Malene Korsholm, Dorte Gyrd-Hansen, Ole Mogensen, Sören Möller, Liza Sopina, Siv L. Joergensen & Pernille T. Jensen. (2019) Long term resource consequences of a nationwide introduction of robotic surgery for women with early stage endometrial cancer. Gynecologic Oncology 154:2, pages 411-419.
Crossref
Gitte Ørtoft, Claus Høgdall, Caroline Juhl, Lone K Petersen, Estrid S Hansen & Margit Dueholm. (2019) Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study. International Journal of Gynecologic Cancer 29:3, pages 497-504.
Crossref
Siv Lykke Jørgensen, Ole Mogensen, Chunsen S. Wu, Malene Korsholm, Ken Lund & Pernille T. Jensen. (2019) Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study. European Journal of Cancer 109, pages 1-11.
Crossref
M. Iachina, P.M. Ljungdalh, R.G. Sørensen, L. Kaerlev, J. Blaakær, O. Trosko, N. Qvist & B.M. Nørgård. (2019) Influence of Prior Psychiatric Disorders on the Treatment Course of Gynaecological Cancer – A Nationwide Cohort Study. Clinical Oncology 31:2, pages 115-123.
Crossref
Gitte Ørtoft, Lisa Lausten-Thomsen, Claus Høgdall, Estrid S Hansen & Margit Dueholm. (2019) Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study. Journal of Gynecologic Oncology 30:5.
Crossref
Mette Hjortkjær, Mads Malik Aagaard Jørgensen, Marianne Waldstrøm, Dorthe Ørnskov, Erik Søgaard-Andersen, Anders Jakobsen & Karina Dahl-Steffensen. (2019) The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer. International Journal of Gynecologic Cancer 29:1, pages 166-173.
Crossref
Sarah M. Sørensen, Tine H. Schnack & Claus Høgdall. (2018) Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB‐IIIC vs stage IV epithelial ovarian cancer after primary surgery. Acta Obstetricia et Gynecologica Scandinavica 98:1, pages 34-43.
Crossref
Nora Elisabeth Hedbäck, Mona Aarenstrup Karlsen, Claus Kim Høgdall & Mikkel Rosendahl. (2018) Survival of selected patients with ovarian cancer treated with fertility-sparing surgery. Reproductive BioMedicine Online 37:1, pages 71-76.
Crossref
Jennifer J. Mueller, Henrik Lajer, Berit Jul Mosgaard, Slim Bach Hamba, Philippe Morice, Sebastien Gouy, Yaser Hussein, Robert A. Soslow, Brooke A. Schlappe, Qin C. Zhou, Alexia Iasonos, Claus Høgdall, Alexandra Leary, Roisin E. O’Cearbhaill & Nadeem R. Abu-Rustum. (2018) International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers. International Journal of Gynecologic Cancer 28:5, pages 915-924.
Crossref
Mette Calundann Noer, Sofie Leisby Antonsen, Bent Ottesen, Ib Jarle Christensen & Claus Høgdall. (2018) Type I Versus Type II Endometrial Cancer: Differential Impact of Comorbidity. International Journal of Gynecologic Cancer 28:3, pages 586-593.
Crossref
Mikkel Rosendahl, Philipp Harter, Signe Frahm Bjørn & Claus Høgdall. (2018) Specific Regions, Rather than the Entire Peritoneal Carcinosis Index, are Predictive of Complete Resection and Survival in Advanced Epithelial Ovarian Cancer. International Journal of Gynecological Cancer 28:2, pages 316-322.
Crossref